Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV
The Panel updated the following section of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Highlights from the section are summarized below:
- Table 18 of this section has been updated to include recommendations regarding concomitant use of fostemsavir or long acting cabotegravir plus rilpivirine with different hepatitis C treatment regimens.
For a complete list of updates, please see What's New in the Guidelines. To view or download the guidelines, go to the Adult and Adolescent ARV Guidelines section of Clinical Info’s website. The guideline tables and recommendations can also be downloaded as separate PDF files.
Clinical Info Welcomes Your Feedback on the latest revisions to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Please send your comments with the subject line “Adult and Adolescent ARV Guidelines” to ContactUs@HIVinfo.NIH.gov by August 27, 2021.